Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022

SELL
$13.8 - $20.82 $171,368 - $258,542
-12,418 Reduced 21.53%
45,252 $939,000
Q1 2022

May 06, 2022

SELL
$15.96 - $18.87 $81,396 - $96,237
-5,100 Reduced 8.12%
57,670 $968,000
Q4 2021

Feb 08, 2022

SELL
$16.79 - $20.37 $179,653 - $217,959
-10,700 Reduced 14.56%
62,770 $1.25 Million
Q3 2021

Oct 25, 2021

SELL
$18.14 - $27.03 $6,893 - $10,271
-380 Reduced 0.51%
73,470 $1.33 Million
Q2 2021

Jul 26, 2021

SELL
$25.24 - $30.86 $8,076 - $9,875
-320 Reduced 0.43%
73,850 $1.99 Million
Q1 2021

May 06, 2021

SELL
$28.29 - $39.89 $25,347 - $35,741
-896 Reduced 1.19%
74,170 $2.22 Million
Q4 2020

Jan 28, 2021

BUY
$24.45 - $31.59 $1.84 Million - $2.37 Million
75,066 New
75,066 $2.16 Million

Others Institutions Holding CVET

About COVETRUS, INC.


  • Ticker CVET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 140,123,008
  • Description
  • Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...
More about CVET
Track This Portfolio

Track Legal Advantage Investments, Inc. Portfolio

Follow Legal Advantage Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal Advantage Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Legal Advantage Investments, Inc. with notifications on news.